SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Advanced Micro Devices - Moderated (AMD) -- Ignore unavailable to you. Want to Upgrade?


To: Road Walker who wrote (47370)7/12/2001 11:05:17 PM
From: Jim McMannisRead Replies (2) | Respond to of 275872
 
RE:"Bill or Steve told you personally? Or are you just making it up? Could it be $35 or $40, or $60?"
No way it's $60. At lot closer to $30 is more like it.

If you don't believe me ask your boy Paul who has said $30 as well...

RE:"Listened to the CC, that Jerry is a pistol. Amazing how he can make an 80% miss, and projections of current quarter loss, sound like success. The deeper AMD gets, the more confident he sounds. Great salesman."

He only looks at success in terms of taking Intel share.
Who was that who said, "damn the torpedoes, full speed ahead"? Well that's Jerry.

Actually if he was running Intel's PR I'd load up on Intel.

Jim



To: Road Walker who wrote (47370)7/12/2001 11:35:59 PM
From: jamok99Respond to of 275872
 
John,

re: <<Listened to the CC, that Jerry is a pistol. Amazing how he can make an 80% miss, and projections of current quarter loss, sound like success. The deeper AMD gets, the more confident he sounds. Great salesman>>

I, personally, am looking forward to sharing a beer with you and the other AMD investors and listening to "The Best of Jerry" audio collection when we're all living together down at the poor farm <g>.

More seriously, I understand Jerry's point, as expounded so well by Charles R, that market share brings a lot of benefits, not the least of which is decent infrastructure support. It's a gutsy gamble - I just worry that if it's the wrong strategy (market share can evaporate quickly with new product performance characteristics/competition - look at TDFX - (well, you can't look at TDFX, it doesn't exist anymore <g>). "Volume is our vaccine" - the question is whether the cure will kill the patient.

Jamok